Finance

Lists
URGN:NASDAQ
Urogen Pharma Ltd
36,61 USD
+0,08%
(+0,030) 1D
36,61 USD
0,00% (0,00)
After hours
Closed: 15-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for URGN...
Open
37,04 USD
High
38,37 USD
Low
36,27 USD
Mkt. cap
1,79 млд
Avg. vol.
903,86 миң
Volume
0,00
52-wk high
50,81 USD
52-wk low
16,36 USD
EPS
-1,98 USD
Beta
1,57
Shares outstanding
48,88 млн
No. of employees
300
Open
37,04 USD
High
38,37 USD
Low
36,27 USD
Mkt. cap
1,79 млд
Avg. vol.
903,86 миң
Volume
0,00
52-wk high
50,81 USD
52-wk low
16,36 USD
EPS
-1,98 USD
Beta
1,57
Shares outstanding
48,88 млн
No. of employees
300
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
17 саат мурун
MarketBeat cites USD 52.38 target for UroGen Pharma stock
Stock Traders Daily
Stock Traders Daily
·
1 күн мурун
(URGN) Risk Channels and Responsive Allocation
About Urogen Pharma Ltd
CEO-
Employees300
Founded2004
HeadquartersНью-Йорк, Нью Йорк, Америка Кошмо Штаттары
Sector-
Websiteurogen.com
Analyst ratings
Based on 5 analysts giving stock ratings to URGN in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for URGN in the last 3 months.
Highest
Current 36,61 USD
75,00 USD (+104,86%)
Average
60,20 USD (+64,44%)
Lowest
48,00 USD (+31,11%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
75,00 USD
+104,9%
08/21/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
60,00 USD
+63,9%
08/06/2026
Paul Choi
Goldman Sachs
Hold
Maintained
48,00 USD
+31,1%
08/05/2026
Michael Schmidt
Guggenheim
Buy
Maintained
58,00 USD
+58,4%
08/05/2026
Tara Bancroft
TD Cowen
Buy
Reiterated
60,00 USD
+63,9%
08/05/2026
Unknown Analyst
Guggenheim
Buy
Maintained
32,00 USD
-12,6%
06/03/2026
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Initiated
43,00 USD
+17,5%
05/11/2026
Kelsey Goodwin
Piper Sandler
Buy
Maintained
40,00 USD
+9,3%
04/20/2026
Amin Makarem
Jefferies
Buy
Initiated
40,00 USD
+9,3%
04/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
27,48 млн
37,84 млн
50,96 млн
72,46 млн
Cost of goods sold
3,28 млн
3,29 млн
4,14 млн
6,57 млн
Cost of revenue
3,28 млн
3,29 млн
4,14 млн
6,57 млн
Research and development expenses
14,01 млн
14,31 млн
15,60 млн
17,34 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37,58 млн
39,35 млн
51,49 млн
48,44 млн
Operating expense
51,59 млн
53,66 млн
67,08 млн
65,77 млн
Total operating expenses
54,87 млн
56,95 млн
71,22 млн
72,34 млн
Operating income
-27,39 млн
-19,12 млн
-20,26 млн
111,00 миң
Other non operating income
-4,82 млн
-4,66 млн
-4,83 млн
-4,89 млн
EBT including unusual items
-34,40 млн
-26,64 млн
-28,35 млн
-8,72 млн
EBT excluding unusual items
-34,40 млн
-26,64 млн
-28,35 млн
-8,72 млн
Income tax expense
-1,05 млн
-275,00 миң
-4,77 млн
5,63 млн
Effective tax rate
3,06%
1,03%
16,83%
-64,54%
Other operating expenses
-
-
-
-
Net income
-33,35 млн
-26,36 млн
-23,57 млн
-14,35 млн
Net profit margin
-121,34%
-69,68%
-46,26%
-19,81%
Earnings per share
-0,69
-0,53
-0,47
-0,28
Interest and investment income
1,18 млн
908,00 миң
931,00 миң
946,00 миң
Interest expense
-3,37 млн
-3,77 млн
-4,18 млн
-4,89 млн
Net interest expenses
-2,20 млн
-2,86 млн
-3,25 млн
-3,94 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-27,31 млн
-19,04 млн
-20,19 млн
189,00 миң
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору